Inhibitory effects of reserpine and carbonyl cyanide m-chlorophenylhydrazone on fluoroquinolone resistance of Acinetobacter baumannii

Chinese Medical Journal

Volumn 118, Issue 4, 2005, Pages 340-343

  Shi, Wei Feng ^a   Jiang, Jian Ping ^a   Xu, Ning ^b   Huang, Zhi Mi ^c   Wang, Yu Yue ^a  

^a SOOCHOW UNIVERSITY   (China)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c The 98th Hospital of PLA   (China)

Author keywords

Acinetobacter baumannii; Carbonyl cyanide m chlorophenylhydrazone; Efflux effect; gyrA; parC; Reserpine

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; FLEROXACIN; LEVOFLOXACIN; LOMEFLOXACIN; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; SPARFLOXACIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; BASE SEQUENCE; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; RESERPINE;

EID: 14644396616     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fluit AC, Visser MR, Schmitz FJ. Molecular detection of antimicrobial resistance. Clin Microbiol Rev 2001;14: 836-871.
2. Van Bamveke F, Balzi E, Tulkens PM. Antibiotic efflux pumps. Biochem Pharmacol 2000;60:457-470.
3. Kaatz GW, Moudgal VV, Seo SM, et al. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2003;47:719-726.
4. Molnar J, Hever A, Fakla I, et al. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells. Anticancer Res 1997; 17: 481-486.
5. Schmitz FJ, Fluit AC, Luckefahr M, et al. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 1998;42:807-810.
6. Kaatz GW, Moudgal VV, Seo SM. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J Antimicrob Chemother 2002;50:833-838.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Approved standard M100-S11. Wayne, PA: NCCLS; 2001.
8. Webber MA, Piddock LJV. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003;51:9-11.
9. Gilbert P, McBain AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev 2003; 16: 189-208.
10. Poole K. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria. Antimicrob Agents Chemother 2000;44:2595-2599.
11. Valdezate S, Vindel A, Echeita A, et al. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob Agents Chemother 2002;46:665-671.
12. Vila J, Ribera A, Marco F, et al. Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2002;49:471-477.
13. Xia P, Feng P, Lu X, et al. Accumulation of ciprofloxacin and lomefloxacinin fluoroquinolone resistant strains of Escherichia coli Chin Med J 2002; 115: 31-35.
14. Varon E, Janoir C, Kitzis MD, et al. ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae. Antimicrob Agents Chemother 1999; 43:302-306.